Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2476 per EA under NDC 33342019010. Its NADAC has been published 493 times since Jan 18, 2017.
Strength
5; 20 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342019010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206884On Market Since
10/27/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 493 times since Jan 18, 2017, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2476 per EA |
|---|---|
| All-time high | $1.0059 (Apr 12, 2017) |
| All-time low | $0.2347 (Apr 22, 2026) |
| 52-week high | $0.3120 |
| 52-week low | $0.2347 |
| Median price | $0.4178 |
| Average price | $0.4797 |
| Largest weekly change | +64.3% (Jul 21, 2021) |
| Weeks tracked | 493 |
| Tracking since | Jan 18, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2476 per EA (NDC 33342019010), effective Jun 24, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 73.3%. It has been tracked across 493 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2347 (Apr 22, 2026) to a high of $1.0059 (Apr 12, 2017), with a median of $0.4178 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 5-20 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 33342019010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification